Biotech and Pharmaceuticals Pharmaceuticals

  • Express Scripts headquarters in St. Louis, Missouri.

    Citron Research tweeted that Express Scripts is "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct.

  • Interior Of A Chemist'S Shop

    Double-digit percentage increases of drugs have been common since 2011, and quadruple-digit prices have been seen for many cheaper medications.

  • DOVER, Del.— British-based pharmaceutical company AstraZeneca says it is eliminating about 700 jobs in its U.S. commercial business, including about 120 at its North American headquarters in Wilmington. AstraZeneca, which once employed close to 5,000 workers in Delaware, announced in 2013 that it was cutting 1,200 jobs at its Wilmington headquarters.

  • WASHINGTON, Dec 8- Drugmaker Bristol-Myers Squibb Co will pay $19.5 million to resolve multi-state allegations that it improperly promoted a schizophrenia treatment for uses not approved by the U.S. government, New York Attorney General Eric Schneiderman said on Thursday. The company's agreement with 42 other states and the District of Columbia centers on...

  • Bristol-Myers Squibb Co. brand medication at a pharmacy in Princeton, Illinois, U.S., on Monday, April 27, 2015.

    Bristol-Meyers Squibb will pay millions to resolve allegations that it improperly promoted a schizophrenia treatment for unapproved uses.

  • WASHINGTON, Dec 8- Drugmaker Bristol-Meyers Squibb Co will pay $19.5 million to resolve multi-state allegations that it improperly promoted a schizophrenia treatment for uses not approved by the U.S. government, New York Attorney General Eric Schneiderman said on Thursday. The company's agreement with 42 other states and the District of Columbia centers...

  • Dec 8- Horizon Pharma Plc's shares tumbled 18 percent after the company ended a late-stage trial that was testing its drug, Actimmune, as a treatment for a rare neuromuscular disorder that has no approved medicines. The drug is already approved by the U.S. Food and Drug Administration for use in two rare, genetic conditions- chronic granulomatous disease and...

  • TOKYO, Dec 8- Japan's Nikkei share average rose on Thursday, fueled by a further rise on Wall Street, but a stronger yen kept gains in check. On Wednesday, the Dow Jones industrial average and the S&P 500 hit fresh records as equities continued their march upward after the last month's vote for Donald Trump as U.S. president-elect. "The fizz has waned," said Stefan...

  • NEW YORK, Dec 7- President-elect Donald Trump took aim at drugmakers on Wednesday by promising in a magazine interview that "I'm going to bring down drug prices," sending shares of pharmaceutical and biotechnology companies lower. In a cover story for Time magazine, which named him its Person of the Year, Trump said: "I don't like what has happened with drug prices."

  • Abbott Laboratories headquarters in Abbott Park, Illinois.

    Alere has suffered a series of damaging business developments in the 10 months following the signing of the agreement, Abbott said.

  • An employee collects newly-manufactured pills at Teva Pharmaceutical Industries.

    Health-care stocks haven't gotten the green light many expected from Hillary Clinton's election loss.

  • Prescription drugs

    Donald Trump says he's going to bring down prescription drug prices. And here's why that's totally possible, says Jake Novak.

  • NEW YORK, Dec 7- President-elect Donald Trump took aim at drugmakers on Wednesday by promising in a magazine interview that "I'm going to bring down drug prices," sending shares of pharmaceutical and biotechnology companies lower. In a cover story for Time magazine, which named him its Person of the Year, Trump said: "I don't like what has happened with drug prices."

  • The non-prosecution agreement, under which GNC will reform some practices, stems from allegations that it sold a misbranded supplement in 2013 called OxyElite Pro Advanced Formula, made by Dallas- based USP Labs. USP Labs was indicted in November 2015 in a federal court in Dallas on charges that it engaged in a conspiracy to import ingredients from China using...

  • DALLAS— Federal authorities say nutritional supplement retailer GNC Holdings has agreed to alter its practices to avoid selling unlawful dietary products. In a statement Wednesday, the U.S. Justice Department said GNC's efforts to ensure the legality of products on its shelves are "lacking." Pittsburgh- based GNC, the world's largest dietary supplement...

  • Donald Trump speaks to supporters during a town hall meeting on March 14, 2016 at the Tampa Convention Center in Tampa , Florida.

    President-elect Donald Trump made his promise, which echoes past criticisms on drug pricing, in an interview for Time magazine's Person of the Year issue.

  • Funtleyder: Healthcare, unlike rest of markets, is in a holding pattern

    Les Funtleyder, ESquared Asset Management, weighs in on Donald Trump's attack against drug prices, and the healthcare sector.

  • Jim O'Neill considered for FDA commissioner

    CNBC's Meg Tirrell reports on who may be leading the FDA under a Trump presidency.

  • NEW YORK, Dec 7- President-elect Donald Trump on Wednesday took aim at drugmakers, promising in a magazine interview that "I'm going to bring down drug prices," and shares of U.S. pharmaceutical and biotechnology companies fell. In a cover story for Time magazine, which named him its Person of the Year, Trump said that "I don't like what has happened with drug prices."

  • Drug pressure deja vu?

    CNBC's Meg Tirrell reports on which names in biotech were hit hardest last year by Hillary Clinton's tweet calling price gouging "outrageous."